Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH)

NCT01330927 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Nocturia
Benign Prostatic Hypertrophy (BPH)

Interventions

DRUG: VA106483

Sponsor

Vantia Ltd